Camille Buffet

WCTC - World Congress on Thyroid Cancer

Camille Buffet is Professor of Endocrinology and Head of the Department of Thyroid and Endocrine Tumor Diseases at Pitié-Salpêtrière Hospital (AP-HP, Sorbonne University) in Paris, one of the leading referral centers for thyroid and endocrine disorders in France. She also leads the Sorbonne University Clinical Research Group on Thyroid Tumors, coordinating translational and clinical research programs focused on thyroid cancer and endocrine neoplasia.

At the national level, she chairs the Thyroid Research Group of the French Society of Endocrinology, which promotes research, education, and collaborative initiatives in thyroid diseases. She coordinates a national training program in endocrine and cervical ultrasound and directs the Inter-University Diploma in Diagnostic and Interventional Thyroid and Endocrine Ultrasound, a postgraduate program dedicated to advancing expertise in thyroid imaging, minimally invasive procedures, and interventional neck ultrasound.

At the European level, she is actively involved in both the European Thyroid Association (ETA) and the European Society of Endocrinology (ESE). She serves on the Education Boards of both societies and is Associate Editor of the European Thyroid Journal. Her clinical and research interests focus on thyroid cancer, endocrine tumors, thyroid ultrasound, molecular oncology, and innovative approaches to the diagnosis and management of thyroid diseases.

https://thyroidworldcongress.com/wp-content/uploads/camille-buffet.jpg

WCTC Mission Statement on Diversity, Equity and Inclusion (DEI)

The World Congress on Thyroid Cancer (WCTC) recognizes as self-evident that we can most effectively educate ourselves and our colleagues about the best care of patients with thyroid nodules and thyroid cancer when all relevant voices – including those of minority, disadvantaged and marginalized individuals – are heard and recognized. For this reason, we are committed to making the World Congress as welcoming as possible to members of all marginalized groups. We support cultural equity for all attendees and faculty, regardless of ethnicity, age, religion, disability, race, gender, sexual orientation, or any other individual or group identity. We will seek to prioritize attendance and program contributions from underrepresented groups in the World Congress. Furthermore, our Committee on Diversity, Equity and Inclusion will measure, analyze and report the effects of our actions regarding inclusive programming, cultural competence, and recognition of contributions from underrepresented groups. Through these means, we will strive to create a culture of access for all individuals, allowing those of all backgrounds and identities to feel welcomed and engaged in the World Congress.

WCTC Mission Statement

The mission of the World Congress on Thyroid Cancer is to:

Develop a collegial multidisciplinary global platform for all specialists for the discussion on the diagnosis, and treatment of thyroid cancer
Create an environment to stimulate research in the field of thyroid oncology
Build the groundwork for future direction in the management and research in thyroid cancer
Foster camaraderie and build relationships to develop opportunities amongst all professional colleagues for exchange of information and experiences as well as research findings

To fulfil our mission the World Congress of Thyroid Cancer Inc. is committed to respect diversity and foster an environment of inclusivity regardless of race, gender, age, ethnicity, cultural heritage, nationality, religious or political beliefs, sexual orientation, gender identity, socio-economic status, veteran, or ability status.

All members of World Congress of Thyroid Cancer Inc. feel responsible to uphold these values.

Main Conference

Sponsored Webinar